Therapeutic Effects of Punica granatum (Pomegranate): An Updated Review of Clinical Trials

S Eghbali, SF Askari, R Avan… - Journal of nutrition and …, 2021 - Wiley Online Library
Punica granatum L. belongs to the Punicaceae family which is distributed around the world.
Different parts of pomegranate like seed, peel, juice, and leaves are rich in potential …

[HTML][HTML] Cinnamon and its possible impact on COVID-19: The viewpoint of traditional and conventional medicine

M Yakhchali, Z Taghipour, MM Ardakani… - Biomedicine & …, 2021 - Elsevier
The COVID-19 global epidemic caused by coronavirus has affected the health and other
aspects of life for more than one year. Despite the current pharmacotherapies, there is still …

[HTML][HTML] Nigella sativa for the treatment of COVID-19: An open-label randomized controlled clinical trial

AE Koshak, EA Koshak, AF Mobeireek… - … Therapies in Medicine, 2021 - Elsevier
Abstract Background Effective treatment for Coronavirus Disease-2019 (COVID-19) is under
intensive research. Nigella sativa oil (NSO) is a herbal medicine with antiviral and …

COVID‐19 metabolism: Mechanisms and therapeutic targets

T Wang, Y Cao, H Zhang, Z Wang, CH Man… - MedComm, 2022 - Wiley Online Library
Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) dysregulates antiviral
signaling, immune response, and cell metabolism in human body. Viral genome and …

Anti-VEGF agents: As appealing targets in the setting of COVID-19 treatment in critically ill patients

A Sahebnasagh, SM Nabavi, HRK Kashani… - International …, 2021 - Elsevier
Recently, the medications used for the severe form of the coronavirus disease-19 (COVID-
19) therapy are of particular interest. In this sense, it has been supposed that anti-VEGF …

[HTML][HTML] Comparison of HPLC and UV spectrophotometric methods for quantification of favipiravir in pharmaceutical formulations

İ Bulduk - Iranian journal of pharmaceutical research: IJPR, 2021 - ncbi.nlm.nih.gov
There is no currently successful method to treat Covid-19 infection. Nevertheless, previously
licensed pharmaceuticals to treat other virus infections are used on an off-label basis either …

[HTML][HTML] COVID-19 therapeutics: Clinical application of repurposed drugs and futuristic strategies for target-based drug discovery

S Kumar, M Basu, P Ghosh, U Pal, MK Ghosh - Genes & Diseases, 2023 - Elsevier
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) causes the complicated
disease COVID-19. Clinicians are continuously facing huge problems in the treatment of …

Efficacy and safety of Levamisole treatment in clinical presentations of non-hospitalized patients with COVID-19: a double-blind, randomized, controlled trial

A Roostaei Firozabad, ZA Meybodi… - BMC infectious …, 2021 - Springer
Background Levamisole has shown clinical benefits in the management of COVID-19 via its
immunomodulatory effect. However, the exact role of Levamisole effect in clinical status of …

Standardised Sonneratia apetala Buch.-Ham. fruit extract inhibits human neutrophil elastase and attenuates elastase-induced lung injury in mice

S Sengupta, N Abhinav, S Singh, J Dutta… - Frontiers in …, 2022 - frontiersin.org
Chronic obstructive pulmonary disease (COPD) along with asthma is a major and increasing
global health problem. Smoking contributes to about 80%–90% of total COPD cases in the …

5-HT/CGRP pathway and Sumatriptan role in Covid-19

HM Al-Kuraishy, AI Al-Gareeb, A Alexiou… - Biotechnology and …, 2022 - Taylor & Francis
ABSTRACT Coronavirus disease 2019 (Covid-19) is a pandemic caused by severe acute
respiratory syndrome coronavirus type 2 (SARS-CoV-2). In Covid-19, there is uncontrolled …